{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Grimann%20S.A.%20de%20C.V.","name":"Grimann S.A. de C.V.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-05T21:27:26.169Z"},"count":1,"matches":[{"id":"aecc48c1da12cb8b","posted_date":"2022-05-31","letter_issue_date":"2022-05-23","company_name":"Grimann S.A. de C.V.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Failure to Comply with Drug Registration and Listing Requirements","canonical_url":"https://api.morvs.ai/fda-warning/aecc48c1da12cb8b"}]}